NexImmune, Inc. - stock earnings
NEXI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -9.9 million USD | ? USD |
| 2023Q2 | -7.6 million USD | ? USD |
| 2023Q1 | 250.8 million USD | ? USD |
| 2022Q4 | -16.3 million USD | ? USD |
| 2022Q3 | -14.6 million USD | ? USD |
| 2022Q2 | -15.8 million USD | ? USD |
| 2022Q1 | -15.0 million USD | ? USD |
| 2021Q4 | -15.5 million USD | ? USD |
| 2021Q3 | -14.6 million USD | ? USD |
| 2021Q2 | -12.2 million USD | ? USD |
| 2021Q1 | -8.5 million USD | ? USD |
| 2020Q4 | -8.0 million USD | ? USD |
| 2020Q3 | -8.6 million USD | ? USD |
| 2020Q2 | -6.9 million USD | ? USD |
| 2020Q1 | -6.3 million USD | ? USD |
| 2019Q4 | -5.1 million USD | ? USD |
NEXI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -43.9 million USD | ? USD |
| 2022 | 514.2 million USD | ? USD |
| 2021 | -51.7 million USD | ? USD |
| 2020 | -31.6 million USD | ? USD |
| 2019 | -20.3 million USD | ? USD |
| 2018 | -12.8 million USD | ? USD |
NEXI
Price: $3.37
52 week price:
Earnings Per Share: -42.05 USD
P/E Ratio: -0.21
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 424800
Market Capitalization: 4.9 million